North Carolina State University is adding a biotechnology and pharmaceutical emphasis as part of its College of Management MBA program.

MBA students can enroll in the new offering next fall.

“Students who complete this concentration will have in-depth knowledge enabling them to deal with both the scientific and management challenges facing this emerging industry,” said Steve Allen, associate dean for graduate programs at the college.

In addition to a core of four courses in entrepreneurship, finance, information technology (IT), marketing, or supply chain management, three courses will be offered in biotechnology and pharmaceutical industries, such as legal and regulatory issues. Full-time MBA students will also serve an internship at a biotechnology or pharmaceutical firm.